Compare Eli Lilly And Co (LLY) vs Tractor Supply Co (TSCO) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

Tractor Supply (TSCO) trades at $30.29, down 0.74% on the day, with a bearish technical signal from moving averages. The company maintains stable revenue growth, reaching $15.52B in 2025, and a net income margin of 6.91%. Recent earnings have shown mixed results, with Q1 2026 missing expectations. Analysts maintain a consensus price target of $38.40, suggesting significant upside potential. The stock offers a dividend, with the next payment scheduled for June 9, 2026.

The outlook for TSCO is cautiously optimistic, supported by a solid fundamental base and analyst confidence, but near-term performance is challenged by consumer spending pressures. Key opportunities include store expansion and strategic partnerships, while risks involve discretionary demand softness and margin compression from rising costs. The stock presents a value proposition for long-term investors seeking exposure to the resilient rural lifestyle market.